The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Arixtra



Mylan IRE Healthcare LimitedEU/1/02/206/031-032

Main Information

Trade NameArixtra
Active SubstancesFondaparinux sodium
Dosage FormSolution for injection in pre-filled syringe
Licence HolderMylan IRE Healthcare Limited
Licence NumberEU/1/02/206/031-032

Group Information

ATC CodeB01AX Other antithrombotic agents
B01AX05 fondaparinux

Status

License statusAuthorised
Licence Issued
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back